
About VMG Pharmaceuticals Private Limited
Data last updated:
VMG Pharmaceuticals Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 July 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100HR2008PTC092142. Its GSTIN is 06AACCV7777L1ZM (Haryana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹11.59 Lakh. It is led by directors including Gauri Pandey and Jose Alejandro Murillo Campos.
Its last annual general meeting (AGM) was held on 24 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Unit No. 807 – 808 Jmd Megapolis Sohan Road Sector – 48, Gurugram, Haryana, India – 122018.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.17 Cr, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹1.63 Cr (net margin -74.9%) and EBITDA of -₹1.48 Cr (EBITDA margin -68.4%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 24% over five years.
The company is associated with 1 brand: Vmg pharmaceuticals. As per MCA filings, the company has open charges of ₹1.51 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.33 Cr; the latest was in April 2013. The company has 5 MSME Form 1 returns on record between 2019 and 2022, listing 21 overdue payments to 10 micro and small suppliers.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website vmgpharmaceuticals.com.
Company details
CIN history
VMG Pharmaceuticals has one previous CIN (Corporate Identification Number): U24100DL2008PTC180997. The current CIN is U24100HR2008PTC092142, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100HR2008PTC092142 | Current |
| U24100DL2008PTC180997 | Previous |
Contact details
VMG Pharmaceuticals Private Limited's registered office is in Gurugram, Haryana. Its website is vmgpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No. 807 – 808 Jmd Megapolis Sohan Road Sector – 48, Gurugram, Haryana, India – 122018
- IndustryPharma, Drug Formulation & Development
To see the full contact details of VMG Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
VMG Pharmaceuticals operates one associated brand: Vmg pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of pharmaceutical products across therapeutic segments in India. | vmgpharmaceuticals.com |
Business activity
The main business activity of VMG Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of VMG Pharmaceuticals Private Limited, buy the company report.
Financials of VMG Pharmaceuticals Private Limited
FY 2024 filings availableVMG Pharmaceuticals Private Limited reported revenue of ₹2.17 Cr (down 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 64% fall in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.48 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.63 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -68.4% | ||||
| Net Profit Margin | -74.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VMG Pharmaceuticals Private Limited, buy the company report.
Board of directors of VMG Pharmaceuticals Private Limited
VMG Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gauri Pandey | Director | 02 Nov 2018 | 7 Years 11 Months | Current |
| Amita Rajesh | Additional Director | 31 Mar 2019 | 7 Years 7 Months | Current |
| Jose Alejandro Murillo Campos | Director | 05 Nov 2008 | 17 Years 11 Months | Current |
Auditor
VMG Pharmaceuticals Private Limited is audited by BAJAJ & GUPTA for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BAJAJ & GUPTA | FY 2024 | 011286N |
Shareholding
The shareholding of VMG Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of VMG Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jan 2024 | 100892669 | Others | ₹72 Lakh | Open | |
| 01 Jan 2024 | 100892044 | Others | ₹40 Lakh | Open | |
| 01 Jan 2024 | 100892040 | Others | ₹24 Lakh | Open | |
| 13 Apr 2022 | 100585601 | Hdfc Bank Limited | ₹15 Lakh | Open |
Total charge records: 4 View all charges
Deals & funding
VMG Pharmaceuticals Private Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.33 Cr; the latest was in April 2013.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Jun 2012 | Funding round | ₹31.5 Lakh | Investors: an individual |
| Jan 2012 | Funding round | ₹20.7 Lakh | Investors: an individual |
| Jun 2011 | Funding round | ₹77 Lakh | Investors: an individual |
| Jun 2011 | Funding round | ₹3.6 Lakh | Investors: 2 individuals |
To see the full deal history of VMG Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
VMG Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Court case (SMST S) | Filed against the company by M/S Swiss Parenterals Ltd, | Pending |
To see the full case history of VMG Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
VMG Pharmaceuticals Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 21 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Therdose Pharma Private Limited | |||
| Drugfarm Laboratories | |||
| Zeiss Pharmaceuticals Private Limited | |||
| Global Pharma Healthcare Private Limited |
To see the full MSME payment records of VMG Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
VMG Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCV7777L1ZM | Haryana | Active | 13 Mar 2019 |
To see the full GST registrations and return filing status of VMG Pharmaceuticals Private Limited, buy the company report.
Recent activity
VMG Pharmaceuticals Private Limited has 7 board changes on record since 2008: 3 appointments and 4 cessations. The latest: Amita Rajesh was appointed as Additional Director on 31 Mar 2019.
2 earlier events are in the company report.
Frequently asked questions
VMG Pharmaceuticals is an active private limited company based in Gurugram, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 July 2008 (18+ years old) and is registered under CIN U24100HR2008PTC092142.
VMG Pharmaceuticals has 3 current directors:
- Gauri Pandey - Director
- Amita Rajesh - Additional Director
- Jose Alejandro Murillo Campos - Director
The latest financial statements of VMG Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 24 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of VMG Pharmaceuticals is 06AACCV7777L1ZM, registered in Haryana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of VMG Pharmaceuticals is U24100HR2008PTC092142. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VMG Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
VMG Pharmaceuticals was incorporated on 17 July 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
VMG Pharmaceuticals has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.33 Cr; the latest was in April 2013.
Amita Rajesh was appointed as Additional Director on 31 Mar 2019. Rajesh Kumar ceased to be Director on 31 Mar 2019. Gauri Pandey was appointed as Director on 02 Nov 2018. VMG Pharmaceuticals has 7 board changes on record in total.
VMG Pharmaceuticals has 5 MSME Form 1 returns on record between 2019 and 2022, listing 21 overdue payments to 10 micro and small suppliers. The latest return was filed on 13 May 2022.
VMG Pharmaceuticals can be reached through the website vmgpharmaceuticals.com. Its registered office is in Gurugram, Haryana, India.

